Table 1.
| RA | CD | MI | T2D | SCZ ISC | SCZ PGC1 | SCZ PGC2 | |
|---|---|---|---|---|---|---|---|
| n1 | 16,016 | 5,309 | 6,042 | 14,919 | 5,953 | 19,548 | 77,195 |
| n2 | 12,078 | 6,785 | 4,861 | 4,862 | 5,120 | 5,120 | 5,120 |
| m | 82,390 | 91,388 | 89,808 | 75,912 | 84,882 | 93,093 | 103,125 |
| 0.18 | 0.44 | 0.48 | 0.49 | – | – | 0.30 | |
| π01 | 0.973 | 0.972 | 0.980 | 0.962 | – | – | 0.95 |
| P1 | 0.248 | 0.394 | 0.491 | 0.416 | 0.423 | 0.477 | 0.425 |
| P2 | 0.126 | 0.273 | 0.396 | 0.396 | 0.515 | 0.515 | 0.515 |
| K1 | 0.01 | 0.01 | 0.06 | 0.08 | 0.01 | 0.01 | 0.01 |
| K2 | 0.01 | 0.01 | 0.06 | 0.08 | 0.01 | 0.01 | 0.01 |
Abbreviations are as follows: RA, rheumatoid arthritis; CD, celiac disease; MI, myocardial infarction; T2D, type II diabetes; SCZ, schizophrenia; ISC, International Schizophrenia Consortium; PGC, Psychiatric Genomics Consortium. Values of and π01 for RA, CD, MI, and T2D were estimated by Stahl et al.13 and subsequently used in our simulations. Those for SCZ are an approximation based on estimates from several studies and methods (Table 5).